A Muted J.P. Morgan, But The Focus Is Execution – And That's Good News

 
• By Jessica Merrill

A lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors, but industry is confidently executing on focused strategies as it welcomes a new decade. The persistent overhang is US drug pricing and political uncertainty.

Golden Gate Bridge at sunrise in San Fransisco, CA
There were lots of takeaways from the J.P. Morgan Healthcare conference • Source: Shutterstock

More from Strategy

More from Business